(Q48073088)

8 February 2018

title

Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression. (English)

1 reference

8 February 2018

author

Stefano Comai

2

1 reference

8 February 2018

Gabriella Gobbi

6

1 reference

8 February 2018

author name string

Maykel F Ghabrash

1

1 reference

8 February 2018

John Tabaka

3

1 reference

8 February 2018

Marie Saint-Laurent

4

1 reference

8 February 2018

Linda Booij

5

1 reference

8 February 2018

publication date

7 October 2015

1 reference

8 February 2018

World Journal of Biological Psychiatry

published in

1 reference

8 February 2018

volume

17

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

165-170

1 reference

8 February 2018

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Antidepressant actions of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Comprehensive review of the psychiatric uses of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Maintenance efficacy of divalproex in the prevention of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Ketamine and the next generation of antidepressants with a rapid onset of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Epigenetics of the depressed brain: role of histone acetylation and methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

Acceptability of Second-Step Treatments to Depressed Outpatients: A STAR*D Report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2015.1073856

10.3109/15622975.2015.1073856

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

26444701

1 reference

8 February 2018